







dualisticunity.com3h ago
The article reports on the first human trial approved in January 2026 for a therapy designed to partially reverse cellular aging using Yamanaka factors — proteins that can reprogram adult cells back to an embryonic-like state. This breakthrough, building on Shinya Yamanaka's Nobe
A brief CBS News New York report by Jessica Moore highlights how artificial intelligence is becoming an essential tool for doctors, assisting with diagnosis, treatment, and routine medical appointments, and giving heart patients more confidence in their care.






news.cuanschutz.edu6h ago

